AYTU BioPharma
AYTU
57 hedge funds and large institutions have $14M invested in AYTU BioPharma in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 15 closing their positions.
13% more capital invested
Capital invested by funds: $12.4M → $14M (+$1.62M)
5% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 19
0.01% more ownership
Funds ownership: 0.04% → 0.05% (+0.01%)
14% less funds holding
Funds holding: 66 → 57 (-9)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.98M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$395K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$212K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$77.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$326K |
| 2 |
Jane Street
New York
|
-$301K |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$142K |
| 4 |
Two Sigma Investments
New York
|
-$138K |
| 5 |
VF
Virtu Financial
New York
|
-$138K |
AYTU Hedge Fund Activity: Q3 2020 in Review
57 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q3 2020, worth a combined $14M — up 13% from $12.4M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of AYTU and 6 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 20 added.
The largest buyer was BlackRock, adding an estimated $2.4M. The largest seller was Bank of America, cutting an estimated $326K.
- 57 institutional investors held AYTU BioPharma (AYTU) as of Q3 2020, down from 66 in Q2 2020.
- Funds reported $14M of AYTU BioPharma stock for Q3 2020, up 13% quarter-over-quarter.
- 6 funds opened new AYTU BioPharma positions in Q3 2020 and 15 closed out, a net change of -9 holders.
- The largest AYTU BioPharma buyer in Q3 2020 was BlackRock, an estimated $2.4M added.
- The largest AYTU BioPharma seller in Q3 2020 was Bank of America, an estimated $326K sold.
Based on aggregated 13F filings for Q3 2020.